Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1996
11/14/1996WO1996035779A2 Method for activating a reversibly inactivated immobilized enzyme by release from an immobilising moiety and its use in nucleicacid amplification reactions
11/14/1996WO1996035777A1 Chimeric enzyme for promoting targeted integration of foreign dna into a host genome
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035718A1 Process for producing erythropoietin containing no animal proteins
11/14/1996WO1996035717A2 Soluble, cleavable substrates of the hepatitis c virus protease
11/14/1996WO1996035716A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996WO1996035715A2 Pcna binding substance
11/14/1996WO1996035709A1 Method for refolding insoluble aggregates of hepatitis c virus protease
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035705A1 Inhibition of transcription factor-mediated transcriptional activation by oligomer strand invasion
11/14/1996WO1996035704A1 Method for detection of neoplastic cells
11/14/1996WO1996035703A1 Human inhibitor of apoptosis gene 1
11/14/1996WO1996035454A1 Stable virus packaging cell lines
11/14/1996WO1996035450A1 Diagnostic tests for a new spirochete, borrelia lonestari
11/14/1996WO1996035449A1 Monoclonal antibodies for the treatment of ulcerative colitis
11/14/1996WO1996035447A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
11/14/1996WO1996035444A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
11/14/1996WO1996035443A1 Treatment for inhibiting the progression of autoimmune disease
11/14/1996WO1996035442A1 Purified expansin proteins
11/14/1996WO1996035439A1 Low molecular yeast active substance extract and process for preparing the same
11/14/1996WO1996035438A1 Oncogene fusion protein peptide vaccines
11/14/1996WO1996032134A3 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
11/14/1996WO1996032087A3 Transgenic fish in the treatment of diabetes
11/14/1996WO1996030526A3 Bacillus thuringiensis alkaline protease and neutral protease genes
11/14/1996WO1996028470A3 Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
11/14/1996WO1996027008A3 Agent for treating tumours and other hyperplasia
11/14/1996WO1996025501A3 Method and composition for regulating apoptosis
11/14/1996WO1996021675A3 Capturing of microorganisms using complement components
11/14/1996WO1996015148A3 Low molecular weight peptidomimetic growth hormone secretagogues
11/14/1996DE19517532A1 HBV-Vektoren und Zellen zu ihrer Bereitstellung HBV vectors and cells to their provision
11/14/1996DE19517430A1 Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode The pharmaceutical dosage form of parathyroid hormone with a two- to six-hour drug release period
11/14/1996DE19516776A1 Chromatin-Regulatorgene Chromatin regulator genes
11/14/1996CA2220917A1 Fibroblast growth factor homologous factor-2 and methods of use
11/14/1996CA2220910A1 Hbv vectors and cells for producing the same
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220670A1 Human inhibitor of apoptosis gene 1
11/14/1996CA2220556A1 Soluble, cleavable substrates of the hepatitis c virus protease
11/14/1996CA2220497A1 Kunitz type protease inhibitors
11/14/1996CA2220427A1 Method for activating a reversibly inactivated immobilized enzyme by release from an immobilising moiety and its use in nucleic acid amplification reactions
11/14/1996CA2219877A1 Treatment for inhibiting the progression of autoimmune disease
11/14/1996CA2219780A1 Method of diagnosing prostate cancer
11/14/1996CA2218554A1 Plant pathogen resistance genes and uses thereof
11/14/1996CA2218529A1 Nucleic acids for treating obesity
11/14/1996CA2218327A1 Pcna binding substance
11/14/1996CA2217994A1 Chimeric enzyme for promoting targeted integration of foreign dna into a host genome
11/13/1996EP0742229A2 Induction of protection against viral infection
11/13/1996EP0742228A1 IGF-1 superagonists
11/13/1996EP0742018A2 Prion inactivation in connective tissue materials
11/13/1996EP0742014A1 MHC-peptide labelled conjugates
11/13/1996EP0741869A1 Specific binding substances for antibodies and their use for immunoassays or vaccines
11/13/1996EP0741793A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
11/13/1996EP0741792A1 Herpesvirus pre-(viral dna replication) enveloped
11/13/1996EP0741791A1 Cd 69 transcriptional regulatory elements
11/13/1996EP0741789A1 Process for the production of a heterologous protein from a methylotrophic yeast
11/13/1996EP0741787A1 Mammalian expression systems for hepatitis c virus envelope genes
11/13/1996EP0741786A1 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection
11/13/1996EP0741785A1 Methods and compositions for stimulating bone cells
11/13/1996EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells
11/13/1996EP0741783A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
11/13/1996EP0741782A1 Glutamate receptor (or eaa receptor) polynucleotides and their uses
11/13/1996EP0741748A1 Monoclonal antibodies specific to vegf receptors and uses thereof
11/13/1996EP0741747A1 Inhibitors of serine proteases, bearing a chelating group
11/13/1996EP0741746A1 Analogs of thymosin alpha 1
11/13/1996EP0741745A1 Hepatitis b vaccine
11/13/1996EP0741715A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
11/13/1996EP0741578A1 Human growth hormone
11/13/1996EP0741576A1 Co-administration of interleukin-3 mutants with colony stimulating factors
11/13/1996EP0741575A1 Human therapeutic uses of bpi protein products
11/13/1996EP0480014B1 SYNTHETIC POLY-Ig RECEPTOR, RECEPTOR-ANTIBODY COMPLEXES, PRODUCTION AND USE THEREOF
11/13/1996EP0474868B1 Method of producing core structure of retro virus and particle produced thereby
11/13/1996EP0434744B1 Serum immunoregulatory polypeptide and uses therefor
11/13/1996EP0373168B1 Polypeptide useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same
11/13/1996CN1135771A DNA sequence coding for a BMP receptor
11/13/1996CN1135760A Anti-thrombus active piptide and preparation method thereof
11/13/1996CN1135759A Membrane protein polypeptide having functions of supporting pre-B cell growth and gene thereof
11/13/1996CN1135718A Method and products for controlling immune responses in mammals
11/12/1996US5574210 Gray leaf spot resistant corn and the production thereof
11/12/1996US5574206 Transgenic mouse carrying a non-infectious HIV genome
11/12/1996US5574205 Homologous recombination for universal donor cells and chimeric mammalian hosts
11/12/1996US5574144 Kainate-binding, human CNS receptors of the EAA4 family
11/12/1996US5574138 Epithelium-derived T-cell factor
11/12/1996US5574137 Recombinant gamma interferons having enhanced stability and methods therefor
11/12/1996US5574136 DNA encoding granulocyte colony-stimulating factor receptor and protein thereof
11/12/1996US5574134 Polypeptide monomers, linearly extended and/or crosslinked forms thereof, and applications thereof
11/12/1996US5574133 Anti-obesity proteins
11/12/1996US5574132 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
11/12/1996US5574024 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
11/12/1996US5574016 Anticoagulants and cardiovascular disorders
11/12/1996US5574012 Analogs of hirudin having anti-platelet activity
11/12/1996US5574009 With peptides bindable with the reovirus type 3 receptor present on the surface of oligodendrocytes
11/12/1996US5574008 Antidiabetic agents
11/12/1996US5574007 Polypeptide capable of interacting with thrombin
11/12/1996US5573944 Yeast cell expressing heterologous receptor kinase
11/12/1996US5573943 Cloning and expression of a rhoptry associated protein of P. falciparum
11/12/1996US5573940 Cells expressing high levels of CD59
11/12/1996US5573939 DNA encoding mammalian retinol binding protein receptor, and corresponding vectors and transformed cells
11/12/1996US5573933 Transgenic pigs
11/12/1996US5573930 DNA encoding various forms of colony stimulating factor-1
11/12/1996US5573929 Escherichia transformed with expression vector
11/12/1996US5573928 Genetic engineering
1 ... 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 ... 2916